SCHEMBL8256955

SCHEMBL8256955

C=C/C=C(\OC)c1ccc(Cl)c(-c2cnc(NC(=O)c3c(F)cncc3F)cn2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IL2 P60568 13/20 0.44
▸ STIM1 Q13586 1/20 0.43
▸ ORAI1 Q96D31 1/20 0.43
▸ ORAI2 Q96SN7 1/20 0.43
▸ KCNQ3 O43525 1/20 0.34
▸ KCNQ2 O43526 1/20 0.34
▸ KCNE1 P15382 1/20 0.34
▸ KCNQ1 P51787 1/20 0.34
▸ KCNQ5 Q9NR82 1/20 0.34
▸ RIPK2 O43353 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ MAOB P27338 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8258264 0.89 IL2 (0.46) IL2STIM1ORAI1ORAI2NPC1
SCHEMBL8256457 0.88 IL2 (0.44) IL2STIM1ORAI1ORAI2KCNQ3
SCHEMBL5554338 0.86 IL2 (0.48) IL2STIM1ORAI1ORAI2KCNQ3
SCHEMBL8257607 0.82 IL2 (0.42) IL2STIM1ORAI1ORAI2KCNQ3
SCHEMBL8260146 0.82 IL2 (0.39) IL2STIM1ORAI1ORAI2NPC1
SCHEMBL8263046 0.82 IL2 (0.48) IL2STIM1ORAI1KCNQ3KCNQ2
SCHEMBL5554283 0.81 IL2 (0.44) IL2STIM1ORAI1ORAI2SMN1; SMN2
SCHEMBL5554256 0.81 IL2 (0.47) IL2STIM1ORAI1ORAI2NPC1
SCHEMBL8256962 0.80 POLB (0.41) STIM1ORAI1ORAI2RIPK2MAOB
SCHEMBL15395779 0.80 STIM1 (0.53) IL2STIM1ORAI1ORAI2KCNQ3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006081391-A2 COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2006-08-03 — — WO disclosed
Send feedback